NCOA2 antibody (N-Term)
Quick Overview for NCOA2 antibody (N-Term) (ABIN6742809)
Target
See all NCOA2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Human NCOA2
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human, Mouse, Rat, Dog, Rabbit, Horse, Pig (100%) Bovine, Guinea pig, Chicken (92%) Xenopus (85%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from N-Terminus of human NCOA2 (Q15596, NP_006531). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Marmoset, Mouse, Rat, Elephant, Dog, Bat, Rabbit, Horse, Pig, Opossum (100%), Bovine, Guinea pig, Turkey, Zebra finch, Chicken (92%), Xenopus (85%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.
Not recommended for: IHC-P -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- NCOA2 (Nuclear Receptor Coactivator 2 (NCOA2))
-
Alternative Name
- NCOA2 / TIF2
-
Background
-
Name/Gene ID: NCOA2
Synonyms: NCOA2, BHLHe75, KAT13C, NCoA-2, HTIF2, SRC2, TIF2, Nuclear receptor coactivator 2 -
Gene ID
- 10499
-
NCBI Accession
- NP_006531
-
UniProt
- Q15596
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Nuclear Hormone Receptor Binding, Regulation of Lipid Metabolism by PPARalpha, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, CXCR4-mediated Signaling Events, Thromboxane A2 Receptor Signaling
Target
-